Primary Site >> Colorectal Cancer
Gene >> STMN1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Observations on the synthesis of carcinoembryonic antigen by an established human colonic carcinoma cell line. PMID: 6255389 Ref: Observations on the synthesis of carcinoembryonic antigen by an established human colonic carcinoma cell line. PMID: 7360484 |
Ref: [Cerebral metastases as the first clinical manifestation of cancer]. PMID: 6177105 Ref: Carcinoembryonic antigen: physician attitudes, patterns of use, and impact upon patient care. PMID: 7067580 |
Ref: Effect of splenectomy on the growth of murine colon tumors. PMID: 6823129 |
Ref: Gender and illness behavior among colorectal cancer patients. PMID: 3564506 |
Ref: Per capita foods/nutrients intake and mortality from gastrointestinal cancers in Japan. PMID: 3112057 Ref: Salvage pathways as targets of chemotherapy. PMID: 3673709 Ref: Amphotericin B: a biological response modifier in targeting against the salvage pathways. PMID: 3675621 |
Ref: [Laser therapy of the lower gastrointestinal tract. A report of experiences]. PMID: 2479815 |
Ref: Radioimmunotherapy of human colon cancer in nude mice. PMID: 2331226 |
Ref: Hyperthermia effects on cytosolic [Ca2+]: analysis at the single cell level by digitized imaging microscopy and cell survival. PMID: 1988097 Ref: Microencapsulation of human cells: its effects on growth of normal and tumour cells in vitro. PMID: 2039691 |
Ref: Release of cell surface proteoglycans from differentiating colon cells proceeds by cleavage of lipophilic anchor peptides. PMID: 1417765 Ref: TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. PMID: 1730743 |
Ref: Altered immunoglobulin A (IgA-1) levels in patients with advanced colorectal adenocarcinoma presenting with normal preoperative levels of carcinoembryonic antigen (CEA). PMID: 7504559 Ref: The role of growth regulatory aberrations in progression of human colon carcinoma. PMID: 8281613 Ref: Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. PMID: 8494782 Ref: Epidermal growth factor induces serine phosphorylation of stathmin in a human colon carcinoma cell line (LIM 1215). PMID: 8514777 |
Ref: Population genetics of tumours. PMID: 8827374 Ref: Time-lag effect of dietary fiber and fat intake ratio on Japanese colon cancer mortality. PMID: 8886335 |
Ref: Potential for prevention of premature death and disease in New Zealand. PMID: 9484426 Ref: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. PMID: 9634050 Ref: Autocrine TGFalpha expression in the regulation of initiation of human colon carcinoma growth. PMID: 9808147 Ref: Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states. PMID: 9813060 Ref: Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. PMID: 9869214 |
Ref: Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys). PMID: 10365751 Ref: Refined physical mapping and genomic structure of the EXTL1 gene. PMID: 10575224 Ref: 1998 Runme Shaw Memorial Lecture: somatic evolution of cancer. PMID: 10575514 Ref: [Cancer incidence among Icelandic female industrial workers.]. PMID: 19439786 |
Ref: Population pharmacokinetic analysis of the major metabolites of capecitabine. PMID: 12194534 Ref: Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer. PMID: 12480194 |
Ref: Pharmaceutical approaches to colon targeted drug delivery systems. PMID: 12753729 Ref: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. PMID: 12839981 |
Ref: Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer. PMID: 14648016 Ref: Supplementation of a diet low in carotenoids with tomato or carrot juice does not affect lipid peroxidation in plasma and feces of healthy men. PMID: 15113949 Ref: Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity. PMID: 15271980 Ref: Deleted-in-colon-cancer protein expression in patients with adenocarcinoma of the urinary tract and a history of colorectal cancer. PMID: 15596185 |
Ref: Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. PMID: 16091732 Ref: Inflammatory bowel disease in Iran: a review of 457 cases. PMID: 16246187 |
Ref: Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. PMID: 16397026 Ref: Estimated effects of hydrazine exposure on cancer incidence and mortality in aerospace workers. PMID: 16477255 Ref: In vitro antioxidant activity and antigenotoxicity of 5-n-alkylresorcinols. PMID: 16506814 Ref: Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. PMID: 16720821 Ref: The increasing incidence of colorectal cancer and the preventive strategy in Japan. PMID: 17059355 |
Ref: Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. PMID: 17360468 Ref: Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. PMID: 17418982 Ref: A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines. PMID: 17572693 |
Ref: Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. PMID: 17944002 Ref: Oxystress inducing antitumor therapeutics via tumor-targeted delivery of PEG-conjugated D-amino acid oxidase. PMID: 17990314 Ref: Is C-reactive protein a prognostic factor of colorectal cancer? PMID: 18172726 Ref: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? PMID: 18565233 Ref: Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. PMID: 18691351 Ref: An updated approach to dysplasia in IBD. PMID: 18766409 Ref: Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer. PMID: 18808175 Ref: Synchronous and metachronous adenocarcinomas of the large intestine. PMID: 18923668 Ref: Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells. PMID: 19034280 |
Ref: Methodological issues in estimating survival in patients with multiple primary cancers: an application to women with breast cancer as a first tumour. PMID: 19250518 Ref: A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis. PMID: 19513025 |
Ref: Incident cancer burden attributable to excess body mass index in 30 European countries. PMID: 19645011 Ref: Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics. PMID: 19653272 Ref: Multiple imputation in a large-scale complex survey: a practical guide. PMID: 19654173 Ref: Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment. PMID: 20012136 Ref: Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan. PMID: 20047861 Ref: Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53. PMID: 20200495 Ref: [Antibody therapy in cancer]. PMID: 20535960 Ref: Reducing referral delays in colorectal cancer diagnosis: is it about how you ask? PMID: 20584706 Ref: Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. PMID: 20806969 Ref: Dr. Frank caldwell garland, june 20, 1950-august 17, 2010. PMID: 21547096 |
Ref: Aspirin: old drug, new uses and challenges. PMID: 21062358 Ref: Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. PMID: 21138335 Ref: Colorectal cancer screening in women: an underutilized lifesaver. PMID: 21257880 Ref: Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. PMID: 21386635 Ref: Cancer incidence within a cohort occupationally exposed to asbestos: a study of dose--response relationships. PMID: 21406385 Ref: In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein. PMID: 21612405 Ref: Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. PMID: 21622897 Ref: Targeted therapies for gastric cancer: current status. PMID: 21812503 Ref: Increased screening colonoscopy rates and reduced racial disparities in the New York Citywide campaign: an urban model. PMID: 22056567 Ref: Design and evaluation of colon targeted modified pulsincap delivery of 5-fluorouracil according to circadian rhythm. PMID: 23071940 |
Ref: Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker. PMID: 22181002 Ref: Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. PMID: 22306039 Ref: Effect of increasing active travel in urban England and Wales on costs to the National Health Service. PMID: 22682466 |
Ref: Vitamin D supplementation and cancer: review of randomized controlled trials. PMID: 23094929 Ref: Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation. PMID: 23273404 Ref: Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. PMID: 23299842 Ref: Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics. PMID: 23552806 |
Ref: Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells. PMID: 23584479 Ref: A novel and essential role for FcgammaRIIa in cancer cell-induced platelet activation. PMID: 24258815 Ref: Folic acid fortification and colorectal cancer risk. PMID: 24512932 Ref: Examining regional variation in the use of cancer screening in Germany. PMID: 24727534 Ref: Colon and rectal cancer incidence and water trihalomethane concentrations in New South Wales, Australia. PMID: 24938491 Ref: Unbiased proteomic and transcript analyses reveal that stathmin-1 silencing inhibits colorectal cancer metastasis and sensitizes to 5-fluorouracil treatment. PMID: 25063586 Ref: Metastatic colorectal cancer treatment patterns according to kirsten rat sarcoma viral oncogene homolog genotype in U.S. Community-based oncology practices. PMID: 25065655 Ref: United States colorectal cancer screening practices among American Indians/Alaska Natives, blacks, and non-Hispanic whites in the new millennium (2001 to 2010). PMID: 25123695 Ref: Development and optimization of polymeric self-emulsifying nanocapsules for localized drug delivery: design of experiment approach. PMID: 25525620 |
Ref: Sociocultural and health correlates related to colorectal cancer screening adherence among urban African Americans. PMID: 24836955 Ref: Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR. PMID: 25445497 Ref: Global burden of cancer attributable to high body-mass index in 2012: a population-based study. PMID: 25467404 Ref: Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. PMID: 25588105 |
Ref: Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. PMID: 26817443 Ref: Vitamin B2 intake and colorectal cancer risk; results from the Nurses' Health Study and the Health Professionals Follow-Up Study cohort. PMID: 27081929 Ref: Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis. PMID: 27236345 Ref: STMN1 in colon cancer: expression and prognosis in Chinese patients. PMID: 27249602 Ref: Testing ERBB2 p.L755S kinase domain mutation as a druggable target in a patient with advanced colorectal cancer. PMID: 27626067 Ref: miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer. PMID: 27904764 Ref: Obesity as an Avoidable Cause of Cancer (Attributable Risks). PMID: 27909911 Ref: A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer. PMID: 27924162 |
Ref: Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life. PMID: 28101676 Ref: Formulation and development of di-dependent microparticulate system for colon-specific drug delivery. PMID: 28138901 Ref: Medicare modernization and diffusion of endoscopy in FFS medicare. PMID: 28281245 Ref: Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus. PMID: 28463757 Ref: Delayed sample arrival at the laboratory does not lead to more false negatives in the Danish population screening for colorectal cancer. PMID: 28933963 Ref: Barriers and Facilitators to Colorectal Cancer Screening Among Rural Women in Community Clinics by Heath Literacy. PMID: 29568788 |
Ref: Cancers in France in 2015 attributable to high body mass index. PMID: 29161609 Ref: Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden. PMID: 29270993 Ref: 'Simple and easy:' providers' and latinos' perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening. PMID: 29319331 Ref: Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. PMID: 29437869 Ref: Label-Free Quantitative Phosphoproteomics Reveals Regulation of Vasodilator-Stimulated Phosphoprotein upon Stathmin-1 Silencing in a Pair of Isogenic Colorectal Cancer Cell Lines. PMID: 29460479 Ref: Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma. PMID: 29502416 Ref: Addressing Racial Disparity in Colorectal Cancer Screening With CT Colonography: Experience in an African-American Cohort. PMID: 29572136 Ref: Potential of Borojoa patinoi Cuatrecasas water extract to inhibit nosocomial antibiotic resistant bacteria and cancer cell proliferation in vitro. PMID: 29658045 Ref: Late effect of the food consumption on colorectal cancer rate. PMID: 29768948 Ref: Risk of secondary rectal cancer and colon cancer after radiotherapy for prostate cancer: a meta-analysis. PMID: 29961918 Ref: KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway. PMID: 30202098 Ref: Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study. PMID: 30209057 |